AI Terminal
JPMorgan Emerging Markets Investment Trust PLC
Director's Dealing • Nov 1, 2023
5169_dirs_2023-11-01_f6fe1a86-fff3-4d1d-898e-a980c9dc93d4.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 0987S
JPMorgan Emerging Mkts Invest Trust
01 November 2023
JPMorgan Emerging Markets Investment Trust plc
(the 'Company')
Legal Entity Identifier: 5493001VPQDYH1SSSR77
Information disclosed in accordance with DTR 3.1.2-A, incorporating Article 19(1) of the Market Abuse Regulation
1 November 2023
| 1. | Details of the person discharging managerial responsibilities / persons closely associated | |||
| a) | Name | Zoe Clements | ||
| 2. | Reason for the notification | |||
| a) | Position / Status | DIRECTOR | ||
| b) | Initial notification/ Amendment | INITIAL NOTIFICATION | ||
| 3. | Details of the issuer | |||
| a) | Name | JPMorgan Emerging Markets Investment Trust Plc | ||
| b) | Legal Identifier Code | 5493001VPQDYH1SSSR77 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 2.5p each ISIN: GB00BMXWN182 |
||
| b) | Nature of the Transaction | Acquisition of shares | ||
| c) | Price and Volume | Price | Volume | |
| 97. 3552 pence | 35,000 | |||
| d) | Aggregated information - Aggregated price - Price |
N/A single transaction |
||
| e) | Total Holding following transaction | 50,000 Ordinary shares | ||
| f) | Date of transaction | 1 November 2023 | ||
| g) | Place of transaction | London Stock Exchange, XLON | ||
For further information:
Alison Vincent
JPMorgan Funds Limited
0800 20 40 20 (or +44 1268 44 44 70)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHDFLFBXFLBFBX